FTC Appeals Big Loss To A Shire Unit In Sham Petition Case

Law360 (April 11, 2018, 9:48 PM EDT) -- The Federal Trade Commission on Wednesday appealed its stinging loss to Shire ViroPharma Inc. in a landmark case that alleges abuse of the U.S. Food and Drug Administration's citizen petition process to delay competition from generic drugs.

In a notice filed in Delaware federal court, the FTC appealed to the Third Circuit a decision last month that derailed its case on procedural grounds. The decision from U.S. District Judge Richard G. Andrews found no evidence that Shire ViroPharma was "about to violate" any law enforced by the FTC and that the case was therefore not authorized under the FTC Act....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!